{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P25025",
      "entity_text" : "CXCR2",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01731",
      "entity_text" : "SB225002",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Similarly, inhibition of CXCR2 by SB225002 effectively impeded CXCR2 mediated ovarian cancer metastasis in vivo has been reported in other human cancer studies XREF_BIBR, XREF_BIBR, suggesting that this type of CXCR2 antagonist could be developed as a potential therapeutic drug for preventing peritoneal metastases.",
  "reading_complete" : "2020-08-03T16:21:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:18:54Z",
  "trigger" : "inhibition",
  "evidence" : [ "inhibition of CXCR2 by SB225002" ],
  "pmc_id" : "5835935",
  "score" : 0
}